Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06120933 · ClinicalTrials.gov registry record · NA
A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health
A NA study of Hair Loss and Hair Health, sponsored by BrandiZone.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06120933: Completed NA study of Hair Loss and Hair Health, sponsored by BrandiZone.
NCT06120933 is a NA study of Hair Loss and Hair Health that has completed, run by BrandiZone. The registered enrollment target is 25 participants, below the 1,353-participant average among 8 other Hair Loss trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06120933, a NA study of Hair Loss and Hair Health, has completed, sponsored by BrandiZone.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial aims to investigate the effectiveness of two Vitamins Revive hair supplements in promoting hair growth, reducing hair loss, and improving overall hair health. The products under assessment are Hair Nutra Growth and Hair Nutra Boost. The trial will assess the efficacy of the products to induce better hair growth, reduction in hair loss and shedding, increased hair thickness and fullness, and improvement in hair appearance and vitality over a 12-week testing period. Participants will complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12. Participants will also provide photos of their hair at Baseline, Week 4, Week 8, and Week 12.
Primary Outcome
Changes in self-reported rate of hair growth will be recorded via study-specific questionnaires. Responses will be on a Likert scale (0-5 scale), with 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Hair Nutra Growth Supplement & Hair Nutra Boost Supplement
- DIETARY_SUPPLEMENT Hair Nutra Growth
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2023-10-06 |
| Phase | NA |
What the finished NCT06120933 record still lists
NCT06120933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,353-participant average among 8 other Hair Loss trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Hair Loss appearing as the primary indexed condition, and to 2 interventions - of which Hair Nutra Growth Supplement & Hair Nutra Boost Supplement is the first listed.
NCT06120933 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06120933 about?
NCT06120933 is a clinical study titled "A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health". This clinical trial aims to investigate the effectiveness of two Vitamins Revive hair supplements in promoting hair growth, reducing hair loss, and improving overall hair health. The products under assessment are Hair Nutra Growth and Hair Nutra Boost. The trial will assess the efficacy of the produ...
What is the current status of trial NCT06120933?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-06-15. Estimated completion is 2023-10-06.
What conditions does trial NCT06120933 study?
This clinical trial studies the following conditions: Hair Loss, Hair Health.
What interventions are being tested in trial NCT06120933?
The interventions under investigation include: Hair Nutra Growth Supplement & Hair Nutra Boost Supplement (DIETARY_SUPPLEMENT), Hair Nutra Growth (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06120933?
This trial is sponsored by BrandiZone, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06120933 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hair Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06120933's enrollment target sits among peer trials
25 8th of 8 higher than 1 of 8 other Hair Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hair Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
RECRUITING · NA
-
Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
RECRUITING · NA
-
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
ACTIVE NOT RECRUITING · NA
-
Impact of a Topical Cosmetic Product on Women's Hair
COMPLETED · NA
-
Blood Specimen Collection For Laboratory Assay Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI